- 5
- 0
- 约2.19万字
- 约 39页
- 2020-04-07 发布于广东
- 举报
* The first human contrast angiogram is said to have taken place in 1919 and employed potassium iodide to opacify the veins of an upper extremity. Subsequently, a variety of other agents were utilized, each accompanied with considerable toxic potential. Selectan, the 1st organic iodide was introduced in 1929 and was followed by a number of modified compounds (eg Uroselectin, Diodrast). In the 1950s agents containing a fully substituted benzene ring containing 3 molecules of iodine was introduced. Since then, a variety of agents have followed that differ in several categories. Osmolality is the ratio of iodine molecules to osmotically active particles in the contrast agent. High osmolar agents have 3 iodine atoms for every 2 osmotically active agents (the cation and anion). Contrast agents in this group have 1500 mOsm/kg. Low osmolar contrast agents have osmolalities in the 600-1000 mOsm/kg range. This is achieved either by 6 iodine atoms per 2 osmotically active particles or by 3 iodine atoms per 1 osmotically active group. Efforts to further reduce osmolality lead to a class of contrast agents with 6 iodine atoms per 1 osmotically active group. After addition of sodium and calcium to the compound, this class possesses an osmolality of 290 mOsm/kg. The ionicity refers to the compound containing an ionizable group. All high osmolar contrast agents are ionic. However, the low osmolar agents can be either ionic or nonionic. The iso-osmolar contrast agents are currently nonionic. Further, the chemical structure of the commercial contrast agent contains either one or two benzene rings. Monomeric contrast agents contain one benzene ring whereas the dimeric contrast agents contain two benzene rings. Finally, the viscosity of the contrast agents differs according to its chemical structure and formulation with the iso-osmolar contrast agents having the highest viscosity. * 1. Harris KG, Smith TP, Cragg AH, Lemke JH. Nephrotoxicity from contrast material i
您可能关注的文档
- 产褥感染护理查房.ppt
- 肠道杆菌教学.ppt
- 垂体柄阻断综合征病例讨论课件.ppt
- 常用腧穴培训.ppt
- 丹参的药用成分及临床研究进展课件.ppt
- 代谢综合征诊治及护理.ppt
- 胆红素脑病的诊断和康复治疗课件.ppt
- 肠道感染细菌讲课.ppt
- 肠梗阻的治疗护理.ppt
- 常见肿瘤的病理分类讲课.ppt
- 宠物行业新品趋势-炼丹炉x淘天集团-202601.docx
- 2025空间智能软件技术大会:GIS+燃气:智慧燃气行业数字化转型.pptx
- 2025年AI治理报告:回归现实主义.docx
- 2025医疗科技领域AI应用:驾驭变革与机遇研究报告 Artificial Intelligence in Medtech Navigating Change and Opportunity.docx
- 2026年50大科技趋势前瞻报告 The Top 50 Technology Trends.docx
- 数字电网无人机巡检解决方案.docx
- 人工智能企业综合能力评价规范(平台化视角)(征求意见稿).docx
- 中国经济复盘与展望:“反内卷”与结构突围.docx
- 爷爷不泡茶茶饮品牌小红书平台推广方案.pptx
- 2026年美中AI市场竞争态势与DeepSeek的突围(中文).docx
最近下载
- 2025年度民主生活会“带头强化政治忠诚提高政治能力方面”五个带头常见存在问题清单.docx VIP
- 糖尿病合并感染..ppt VIP
- 2025年全国高考体育单招考试政治试卷真题及答案解析.docx VIP
- 浅谈赵师侠词的思想内容.doc VIP
- 【水利】2021年一级建造师考试逆袭卷(一).docx VIP
- 中建《项目商务策划管理办法》.docx VIP
- 实施指南(2026)《NBT 25044.6-2016 核电厂常规岛及辅助配套设施建设施工质量验收规程 第 6 部分:管道》解读.pptx VIP
- CAN总线通信需求规范.docx VIP
- DB65T4185-2019 公路雪害防治技术规范.pdf VIP
- 公路养护及占道施工作业安全检查表、人员、车辆、机具设备管理用表、进、出场登记表、安全设施图表.pdf VIP
原创力文档

文档评论(0)